KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 119 filers reported holding KURA ONCOLOGY INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $45,326 | +1252.6% | 2,125 | +812.0% | 0.00% | – |
| Q4 2023 | $3,351 | -95.9% | 233 | -97.0% | 0.00% | – |
| Q2 2023 | $81,942 | -18.9% | 7,745 | +23.0% | 0.00% | – |
| Q1 2022 | $101,000 | +65.6% | 6,296 | +93.0% | 0.00% | – |
| Q3 2021 | $61,000 | +8.9% | 3,263 | +21.9% | 0.00% | – |
| Q2 2021 | $56,000 | -26.3% | 2,676 | 0.0% | 0.00% | – |
| Q1 2021 | $76,000 | -78.6% | 2,676 | -75.3% | 0.00% | -100.0% |
| Q4 2020 | $355,000 | +1167.9% | 10,855 | +1069.7% | 0.00% | – |
| Q3 2020 | $28,000 | -44.0% | 928 | -70.0% | 0.00% | – |
| Q2 2020 | $50,000 | +177.8% | 3,091 | +72.2% | 0.00% | – |
| Q1 2020 | $18,000 | -48.6% | 1,795 | -29.7% | 0.00% | – |
| Q4 2019 | $35,000 | +218.2% | 2,552 | +235.3% | 0.00% | – |
| Q4 2018 | $11,000 | -15.4% | 761 | +0.5% | 0.00% | – |
| Q3 2018 | $13,000 | +18.2% | 757 | +24.7% | 0.00% | – |
| Q2 2018 | $11,000 | +10.0% | 607 | +9.8% | 0.00% | – |
| Q1 2018 | $10,000 | – | 553 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,849,947 | $25,899,000 | 5.33% |
| Asymmetry Capital Management, L.P. | 502,275 | $7,032,000 | 3.73% |
| Affinity Asset Advisors, LLC | 560,000 | $7,840,000 | 2.85% |
| Deep Track Capital, LP | 2,550,000 | $35,700,000 | 2.52% |
| ACUTA CAPITAL PARTNERS, LLC | 291,884 | $4,086,000 | 1.72% |
| EcoR1 Capital, LLC | 3,724,437 | $52,142,000 | 1.66% |
| SPHERA FUNDS MANAGEMENT LTD. | 832,238 | $11,651,000 | 1.28% |
| Ghost Tree Capital, LLC | 225,000 | $3,150,000 | 1.13% |
| BVF INC/IL | 2,064,212 | $28,899,000 | 1.05% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,513,756 | $49,193,000 | 1.03% |